3α,21-Dihydroxy-5α-pregnane-11,20-dione
CAS: 14107-37-0
Ref. 3D-FD17323
| 1mg | Descatalogado | ||
| 2mg | Descatalogado | ||
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado |
Información del producto
Nombre:
3α,21-Dihydroxy-5α-pregnane-11,20-dione
Producto controlado
Sinónimos:
- (3α,5α)-3,21-Dihydroxypregnane-11,20-dioneAlphadolone
- (3Α,5Α)-3,21-Dihydroxypregnane-11,20-Dione
- 3-alpha,21-Dihydroxy-5-alpha-pregnane-11,20-dione
- 3alpha,21-Dihydroxy-5alpha-pregnane-11,20-dione
- 5-alpha-Pregnane-11,20-dione, 3-alpha,21-dihydroxy-
- 5α-Pregnane-11,20-dione, 3α,21-dihydroxy-
- 5α-Pregnane-3α,21-diol-11,20-dione
- Alfadolona
- Alfadolona [INN-Spanish]
- Alfadolone [INN:DCF]
- Ver más sinónimos
- Alfadolonum
- Alfadolonum [INN-Latin]
- Alphadolone
- Gr 2/1574
- Pregnane-11,20-dione, 3,21-dihydroxy-, (3α,5α)-
- Unii-Oe1C96974E
- Alfadolone
Descripción:
3a,21-Dihydroxy-5a-pregnane-11,20-dione (3A,21P) is a nitrous oxide metabolite produced by the enzyme cytochrome P450. It has been shown to have low potency as an anaesthetic and to have a clinical relevance in the treatment of postoperative pain. 3A,21P has been found to be antinociceptive in animal models and may act through the gamma-aminobutyric acid system. It is also involved in neuronal function and polymorphonuclear leucocytes. 3A,21P is not currently used clinically for any indication. The mechanism of action for this molecule is not known with certainty but it may inhibit the formation of prostaglandins or increase sensitivity to GABA receptors.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
348.48 g/mol
Fórmula:
C21H32O4
Pureza:
Min. 95%
Color/Forma:
Powder
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
